[1]
Freese, C. et al. 2018. The volume of PET-defined, active bone marrow spared predicts acute hematologic toxicities in anal cancer patients receiving concurrent chemoradiotherapy. Acta Oncologica. 57, 5 (May 2018), 683–686. DOI:https://doi.org/10.1080/0284186X.2017.1377847.